Valeant Cesamet Slated To Hit Market In “Next Several Weeks”
This article was originally published in The Pink Sheet Daily
Executive Summary
Approval comes with indication restricting use to patients who don’t respond to conventional antiemetics due to concern over “disturbing psychotomimetic reactions.”